论文部分内容阅读
《中国药物评价》杂志(ISSN 2095-3593、CN 10-1056/R)是由国家食品药品监督管理总局主管、国家食品药品监督管理局信息中心主办的医药科技期刊,致力于上市药物的评价研究,旨在加强用药安全和合理用药指导,为药品使用和监督决策提供参考。读者对象为一线临床医师、药师,医药科研、生产、经营、教育、服务机构的专业人士,以及各级药品监管、医药卫生、医药行业管理、社会保障等政府部门的人员。主要栏目有:药物管理(包括证据与决策、药物研究的伦理与科学、警戒与通报)、药品评价(包括基础研究、临床研究、循证医学评价、系统评价Meta分析等)、评价技术与方法、药物研究、药物经济学评
China National Journal of Pharmaceutical Evaluation (ISSN 2095-3593, CN 10-1056 / R) is a Chinese medical journal run by the State Food and Drug Administration and sponsored by the Information Center of the State Food and Drug Administration. It focuses on the evaluation of marketed drugs , Aimed at strengthening drug safety and rational drug use guidance, provide reference for drug use and supervision and decision-making. Readers for first-line clinicians, pharmacists, medical research, production, management, education, service agencies professionals, and at all levels of drug regulatory, medical and health, pharmaceutical industry management, social security and other government departments. The main columns are: drug management (including evidence and decision-making, ethics and science of drug research, alert and notification), drug evaluation (including basic research, clinical research, evidence-based medical evaluation, meta-analysis of systematic reviews), evaluation techniques and methods , Drug research, pharmacoeconomics review